Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

BRENDA Home
show all | hide all No of entries

Information on EC 3.2.1.183 - UDP-N-acetylglucosamine 2-epimerase (hydrolysing) and Organism(s) Homo sapiens and UniProt Accession Q9Y223

for references in articles please use BRENDA:EC3.2.1.183
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
IUBMB Comments
The enzyme is found in mammalian liver, as well as in some pathogenic bacteria including Neisseria meningitidis and Staphylococcus aureus. It catalyses the first step of sialic acid (N-acetylneuraminic acid) biosynthesis. The initial product formed is the alpha anomer, which rapidly mutarotates to a mixture of anomers . The mammalian enzyme is bifunctional and also catalyses EC 2.7.1.60, N-acetylmannosamine kinase. cf. EC 5.1.3.14, UDP-N-acetylglucosamine 2-epimerase (non-hydrolysing).
Specify your search results
Select one or more organisms in this record: ?
This record set is specific for:
Homo sapiens
UNIPROT: Q9Y223
Show additional data
Do not include text mining results
Include (text mining) results
Include results (AMENDA + additional results, but less precise)
Word Map
The taxonomic range for the selected organisms is: Homo sapiens
The expected taxonomic range for this enzyme is: Bacteria, Archaea, Eukaryota
Synonyms
bifunctional udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase, bifunctional udp-glcnac 2-epimerase/mannac kinase, uridine diphosphate-n-acetylglucosamine-2-epimerase, uridine diphosphate-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase, more
SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
bifunctional enzyme UDP-Nacetylglucosamine 2-epimerase/N-acetylmannosamine kinase
-
bifunctional UDP-GlcNAc 2-epimerase/ManNAc kinase
-
bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
hydrolyzing epimerase
-
hydrolyzing UDP-GlcNAc 2-epimerase
-
neuC
-
-
-
-
siaA
-
-
-
-
UDP-GlcNAc 2-epimerase
-
UDP-GlcNAc 2-epimerase/ManNAc kinase
-
UDP-GlcNAc-2-epimerase
-
UDP-GlcNAc-2-epimerase/ManAc kinase
UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
UDP-N-acetylglucosamine 2-epimerase/Nacetylmannosamine kinase
-
UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase
uridine diphosphate-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
-
uridine diphosphate-N-acetylglucosamine-2-epimerase
-
additional information
cf. EC 2.7.1.60
REACTION
REACTION DIAGRAM
COMMENTARY hide
ORGANISM
UNIPROT
LITERATURE
UDP-N-acetyl-alpha-D-glucosamine + H2O = N-acetyl-D-mannosamine + UDP
show the reaction diagram
catalytic and regulatory mechanisms
SYSTEMATIC NAME
IUBMB Comments
UDP-N-acetyl-alpha-D-glucosamine hydrolase (2-epimerising)
The enzyme is found in mammalian liver, as well as in some pathogenic bacteria including Neisseria meningitidis and Staphylococcus aureus. It catalyses the first step of sialic acid (N-acetylneuraminic acid) biosynthesis. The initial product formed is the alpha anomer, which rapidly mutarotates to a mixture of anomers [2]. The mammalian enzyme is bifunctional and also catalyses EC 2.7.1.60, N-acetylmannosamine kinase. cf. EC 5.1.3.14, UDP-N-acetylglucosamine 2-epimerase (non-hydrolysing).
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
UDP-N-acetyl-alpha-D-glucosamine + H2O
N-acetyl-D-mannosamine + UDP
show the reaction diagram
additional information
?
-
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
UDP-N-acetyl-alpha-D-glucosamine + H2O
N-acetyl-D-mannosamine + UDP
show the reaction diagram
additional information
?
-
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
CMP-Neu5Ac
CMP-sialic acid
-
feedback inhibition
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
additional information
-
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.0005 - 0.0331
UDP-N-acetyl-alpha-D-glucosamine
TURNOVER NUMBER [1/s]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.076 - 11.8
UDP-N-acetyl-alpha-D-glucosamine
kcat/KM VALUE [1/mMs-1]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
65.4 - 356.5
UDP-N-acetyl-alpha-D-glucosamine
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
7.5
assay at
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
37
assay at
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
additional information
quantitative real-time PCR.expression and tissue localization analysis of isozymes GNE1-GNE8, isozymes hGNE1 and hGNE6 is localized ubiquitously in all tissues examined
Manually annotated by BRENDA team
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
cytoplasmic side of the Golgi membrane
Manually annotated by BRENDA team
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
malfunction
metabolism
physiological function
additional information
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION?
GLCNE_HUMAN
722
0
79275
Swiss-Prot
other Location (Reliability: 5)
PDB
SCOP
CATH
UNIPROT
ORGANISM
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
80000
-
x * 80000, recombinant wild-type and mutant enzymes, SDS-PAGE
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
?
-
x * 80000, recombinant wild-type and mutant enzymes, SDS-PAGE
oligomer
x * 79000, SDS-PAGE
tetramer
additional information
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
enzyme in complex with UDP-GlcNAc, X-ray diffraction crystal structure determination and analysis at 2.7 A resolution. Only UDP is observed in the active site of each monomer despite the use of UDP-GlcNAc in crystallization, presumably the substrate has been converted to ManNAc and UDP before it is trapped in the crystal
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
A287V
naturally occuring mutation, pathogenic variant with possible effect on splicing, severe phenotype
C13S
naturally occuring heterozygous missense mutation of a Chinese distal myopathy (DMRV) patient, phenotype, overview. A c.131G->C homozygous missense mutation on exon 3, leading to a C13S amino acid change
C612F
naturally occuring mutation, pathogenic variant without effect on splicing, severe phenotype
C617Y
naturally occuring mutation, pathogenic variant without effect on splicing, severe phenotype
D112A
site-directed mutagenesis, the mutant shows 97.7% reduced activity compared to the wild-type enzyme
D143A
D176V
D227Y
naturally occuring mutation, pathogenic variant without effect on splicing, severe phenotype
D239E
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, , mild phenotype
D239N
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, mild phenotype
D244V
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, moderate phenotype
D316H
naturally occuring mutation, pathogenic variant without effect on splicing, severe phenotype
E134A
site-directed mutagenesis, inactive mutant
E33G
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, severe phenotype
G237S
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, moderate phenotype
G395R
naturally occuring mutation, pathogenic variant, effect on splicing is uncertain, severe phenotype
G576R
naturally occuring heterozygous missense mutation of a Chinese distal myopathy (DMRV) patient, phenotype, overview. A c.1726G->C heterozygous missense mutation, located on exon 10, resulting in a G576R amino acid change
G590R
naturally occuring mutation, pathogenic variant with possible effect on splicing, severe phenotype
G700R
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, severe phenotype
H179Q
naturally occuring mutation, pathogenic variant with possible effect on splicing, severe phenotype
H251P
naturally occuring mutation, pathogenic variant without effect on splicing, severe phenotype
K406N
naturally occuring mutation, pathogenic variant without effect on splicing, moderate phenotype
L682R
naturally occuring mutation, pathogenic variant without effect on splicing, severe phenotype
M60R
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, severe phenotype
M743T
a naturally occuring GNE myopathy mutant, located at the last exon 13 of the gene
M91V
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, mild phenotype
R113A
site-directed mutagenesis, inactive mutant
R512P
naturally occuring mutation, pathogenic variant without effect on splicing, moderate phenotype
R90X
naturally occuring mutation, pathogenic variant with possible effect on splicing, severe phenotype
S302A
site-directed mutagenesis, the mutant shows 87.1% reduced activity compared to the wild-type enzyme
V572L
Y465C
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, moderate phenotype
additional information
GENERAL STABILITY
ORGANISM
UNIPROT
LITERATURE
the binding of UDP-GlcNAc to an allosteric site may stabilize the closed, active conformation of the enzyme, whereas the open form seems to be not active
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
expression of recombinant wild-type and mutant enzymes
-
gene GNE
-
gene gne, genotyping, transcriptional analysis of the GNE variant c.717T>G, recombinant expression of splicing mutant c.717T>G in HEK 293 cells
gene gne, located on chromosome 9p13.3, genotyping
gene gne, overexpresion of wild-type and mutant enzymes in HEK-293 cells, the endogenous GNE is knocked down in HEK-293 cells using GNE-specific shRNA
gene gne, recombinant expression of N-terminally FLAG3-tagged wild-type and mutant M743T in HEK-293 cells
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
biotechnology
-
a GNE-deficient HEK293 cell line proves its potential for the production of glycoproteins with modified sialylation, gaining therapeutic and diagnostic glycoproteins, and efficient application of metabolic oligosaccharide engineering
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Moeller, H.; Boehrsch, V.; Lucka, L.; Hackenberger, C.P.; Hinderlich, S.
Efficient metabolic oligosaccharide engineering of glycoproteins by UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) knock-down
Mol. Biosyst.
7
2245-2251
2011
Homo sapiens
Manually annotated by BRENDA team
Yardeni, T.; Choekyi, T.; Jacobs, K.; Ciccone, C.; Patzel, K.; Anikster, Y.; Gahl, W.A.; Kurochkina, N.; Huizing, M.
Identification, tissue distribution, and molecular modeling of novel human isoforms of the key enzyme in sialic acid synthesis, UDP-GlcNAc 2-epimerase/ManNAc kinase
Biochemistry
50
8914-8925
2011
Homo sapiens (Q9Y223)
Manually annotated by BRENDA team
Grover, S.; Arya, R.
Role of UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase (GNE) in beta1-integrin-mediated cell adhesion
Mol. Neurobiol.
50
257-273
2014
Homo sapiens
Manually annotated by BRENDA team
Ko, T.P.; Lai, S.J.; Hsieh, T.J.; Yang, C.S.; Chen, Y.
The tetrameric structure of sialic-acid-synthesizing UDP-GlcNAc 2-epimerase from Acinetobacter baumannii a comparative study with human GNE
J. Biol. Chem.
293
10119-10127
2018
Homo sapiens (Q9Y223), Homo sapiens
Manually annotated by BRENDA team
Grover, S.; Arya, R.
Role of UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase (GNE) in beta-integrin-mediated cell adhesion
Mol. Neurobiol.
50
257-273
2014
Homo sapiens (Q9Y223)
Manually annotated by BRENDA team
Harazi, A.; Becker-Cohen, M.; Zer, H.; Moshel, O.; Hinderlich, S.; Mitrani-Rosenbaum, S.
The interaction of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) and alpha-actinin 2 is altered in GNE myopathy M743T mutant
Mol. Neurobiol.
54
2928-2938
2017
Homo sapiens (Q9Y223)
Manually annotated by BRENDA team
Liu, N.; Wang, Z.K.; Wang, H.X.; Li, Y.; Niu, Z.H.; Yu, X.F.
Muscle biopsy and UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene mutation analysis in two Chinese patients with distal myopathy with rimmed vacuoles
NeuroReport
26
598-601
2015
Homo sapiens (Q9Y223)
Manually annotated by BRENDA team
Chen, S.C.; Huang, C.H.; Lai, S.J.; Yang, C.S.; Hsiao, T.H.; Lin, C.H.; Fu, P.K.; Ko, T.P.; Chen, Y.
Mechanism and inhibition of human UDP-GlcNAc 2-epimerase, the key enzyme in sialic acid biosynthesis
Sci. Rep.
6
23274
2016
Homo sapiens (Q9Y223)
Manually annotated by BRENDA team
Cerino, M.; Gorokhova, S.; Behin, A.; Urtizberea, J.A.; Kergourlay, V.; Salvo, E.; Bernard, R.; Levy, N.; Bartoli, M.; Krahn, M.
Novel pathogenic variants in a french cohort widen the mutational spectrum of GNE myopathy
J. Neuromuscul. Dis.
2
131-136
2015
Homo sapiens (Q9Y223)
Manually annotated by BRENDA team